Cargando…
What Is the Significance of Lysosomal-Mediated Resistance to Imatinib?
The lysosomal sequestration of hydrophobic weak-base anticancer drugs is one proposed mechanism for the reduced availability of these drugs at target sites, resulting in a marked decrease in cytotoxicity and consequent resistance. While this subject is receiving increasing emphasis, it is so far onl...
Autor principal: | Mlejnek, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000661/ https://www.ncbi.nlm.nih.gov/pubmed/36899844 http://dx.doi.org/10.3390/cells12050709 |
Ejemplares similares
-
The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
por: Ruzickova, Eliska, et al.
Publicado: (2019) -
Lysosomal Fusion: An Efficient Mechanism Increasing Their Sequestration Capacity for Weak Base Drugs without Apparent Lysosomal Biogenesis
por: Skoupa, Nikola, et al.
Publicado: (2020) -
Direct Interaction between N-Acetylcysteine and Cytotoxic Electrophile—An Overlooked In Vitro Mechanism of Protection
por: Mlejnek, Petr
Publicado: (2022) -
Lipases in lysosomes, what for?
por: Czaja, Mark J., et al.
Publicado: (2009) -
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
por: Rink, Lori, et al.
Publicado: (2013)